A new drug called lepodisiran may offer hope to millions of people at risk of heart attacks and strokes by targeting a little ...

President Donald Trump's recent policies have created turbulence in the global health sector. Key impacts include Indian ...

While manufacturers of FDA-approved injectable pentobarbital are warning states not to use the sedative in executions, some ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

New Jersey lawmakers have the opportunity to close a glaring drug-price loophole and give patients the transparency they’ve been promised.

A group of Canadian undergrads is using plants to revolutionize medicine. Faced with soaring drug prices and global shortages ...

President Trump's administration has instigated significant changes affecting the pharmaceutical sector and healthcare ...

In a last-minute move Wednesday, the Trump administration excluded pharmaceuticals from its retaliatory tariffs, giving consumers a break for now.

Researchers have uncovered two key brain mechanisms—specific neurons and a serotonin receptor—that help explain how ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.